Hiroshi Kida Selected Research

Vaccines

5/2022	Inactivated Whole Virus Particle Influenza Vaccine Induces Anti-Neuraminidase Antibodies That May Contribute to Cross-Protection against Heterologous Virus Infection.
1/2022	Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques.
1/2021	Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.
1/2021	Selecting and Using the Appropriate Influenza Vaccine for Each Individual.
12/2020	Potency of an Inactivated Influenza Vaccine against a Challenge with A/Swine/Missouri/A01727926/2015 (H4N6) in Mice for Pandemic Preparedness.
7/2020	Influenza Vaccination-associated Acute Thrombocytopenia and Diffuse Alveolar Hemorrhage.
1/2020	A cloned classical swine fever virus derived from the vaccine strain GPE- causes cytopathic effect in CPK-NS cells via type-I interferon-dependent necroptosis.
1/2019	Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
11/2018	MicroRNA-451a in extracellular, blood-resident vesicles attenuates macrophage and dendritic cell responses to influenza whole-virus vaccine.
5/2017	Antigenic diversity of H5 highly pathogenic avian influenza viruses of clade 2.3.4.4 isolated in Asia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Kida Research Topics

Disease

55	Infections 05/2022 - 07/2002
46	Influenza in Birds (Avian Flu) 01/2022 - 08/2002
44	Human Influenza (Influenza) 05/2022 - 08/2002
17	Neoplasms (Cancer) 07/2022 - 10/2010
15	Virus Diseases (Viral Diseases) 05/2022 - 01/2008
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2021 - 08/2011
10	Lung Diseases (Lung Disease) 01/2022 - 01/2013
10	Inflammation (Inflammations) 10/2021 - 05/2011
9	Chronic Obstructive Pulmonary Disease (COPD) 02/2022 - 03/2006
8	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2018 - 10/2010
7	Idiopathic Interstitial Pneumonias 01/2022 - 10/2014
7	Fibrosis (Cirrhosis) 10/2020 - 07/2002
6	Lung Neoplasms (Lung Cancer) 07/2022 - 01/2013
5	Pneumonia (Pneumonitis) 01/2022 - 05/2009
5	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 07/2012
5	Idiopathic Pulmonary Fibrosis 01/2022 - 02/2004
5	Disease Progression 01/2021 - 10/2010
5	Neoplasm Metastasis (Metastasis) 02/2017 - 10/2010
5	Diarrhea 05/2015 - 02/2008
4	Pulmonary Alveolar Proteinosis 01/2021 - 11/2014
4	Respiratory Insufficiency (Respiratory Failure) 05/2020 - 11/2014
4	Classical Swine Fever (Swine Fever) 01/2020 - 08/2012
4	Adenocarcinoma of Lung 11/2019 - 01/2012
3	Asthma (Bronchial Asthma) 12/2021 - 03/2006
3	Emphysema 01/2021 - 05/2011
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2014 - 07/2002
2	Body Weight (Weight, Body) 01/2021 - 11/2010
2	Viral Pneumonia 01/2021 - 01/2017
2	Bronchiectasis 10/2020 - 06/2020
2	Thrombocytopenia (Thrombopenia) 07/2020 - 01/2013
2	Autoimmune Diseases (Autoimmune Disease) 02/2020 - 01/2017
2	Sarcoidosis (Schaumann Disease) 02/2020 - 01/2017
2	Lung Injury 01/2020 - 01/2015

Drug/Important Bio-Agent (IBA)

41	VaccinesIBA 05/2022 - 08/2002
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2006
14	Hemagglutinins (Hemagglutinin)IBA 11/2021 - 08/2002
13	Neuraminidase (Sialidase)IBA 05/2022 - 07/2003
12	Antiviral Agents (Antivirals)IBA 01/2022 - 04/2002
8	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2022 - 09/2008
8	AntibodiesIBA 05/2022 - 08/2002
8	CytokinesIBA 10/2021 - 07/2002
8	AntigensIBA 01/2020 - 01/2005
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2018
6	TetraspaninsIBA 01/2018 - 05/2009
6	Pharmaceutical PreparationsIBA 01/2015 - 06/2011
5	Ether (Diethyl Ether)IBA 01/2022 - 06/2008
5	AutoantibodiesIBA 01/2022 - 11/2014
5	Oseltamivir (Tamiflu)FDA Link 01/2022 - 11/2011
5	ChemokinesIBA 01/2021 - 06/2012
5	peramivirIBA 03/2017 - 11/2010
5	Monoclonal AntibodiesIBA 01/2017 - 01/2006
5	Amino Acids FDA Link 02/2016 - 12/2004
4	Clostridium perfringens epsilon-toxinIBA 02/2022 - 01/2020
4	Oxygen (Dioxygen)IBA 02/2022 - 10/2014
4	Immunoglobulin A (IgA)IBA 01/2022 - 01/2015
4	Formaldehyde (Formol)FDA Link 01/2022 - 07/2003
4	baloxavirIBA 01/2022 - 01/2019
4	Biological ProductsIBA 10/2021 - 02/2004
4	ThrombomodulinIBA 01/2021 - 01/2013
4	Viral RNAIBA 01/2021 - 03/2006
4	Interferon Type IIBA 01/2016 - 10/2010
3	Immunoglobulin E (IgE)IBA 11/2021 - 07/2005
3	Peptides (Polypeptides)IBA 11/2021 - 01/2012
3	Pancreatic Elastase (Elastase)IBA 01/2021 - 05/2011
3	EndonucleasesIBA 01/2021 - 12/2018
3	Neutralizing AntibodiesIBA 12/2020 - 08/2009
3	Polysaccharides (Glycans)IBA 04/2020 - 02/2013
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 04/2020 - 11/2010
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 07/2002
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 05/2003
3	ErbB Receptors (EGF Receptor)IBA 02/2017 - 07/2012
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 04/2012
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2013 - 04/2012
3	Viral AntigensIBA 01/2006 - 11/2003
2	Phosphates (Orthophosphate)IBA 07/2022 - 01/2022
2	Viral Envelope ProteinsIBA 11/2021 - 07/2003
2	Zanamivir (Relenza)FDA Link 11/2021 - 01/2021
2	Bevacizumab (Avastin)FDA Link 07/2021 - 01/2013
2	Interferon-alpha (Interferon Alfa)IBA 01/2021 - 01/2020
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021 - 11/2014
2	Surface-Active Agents (Surfactants)IBA 01/2021 - 02/2004
2	C-Reactive ProteinIBA 01/2021 - 02/2004
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 08/2011
2	Detergents (Detergent)IBA 01/2021 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 03/2010
2	Interleukin-13IBA 01/2021 - 01/2017
2	AcidsIBA 12/2020 - 06/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 01/2019
2	EnzymesIBA 01/2020 - 02/2004
2	Insulin (Novolin)FDA Link 01/2020 - 02/2004
2	pembrolizumabIBA 11/2019 - 01/2019
2	Immune Checkpoint InhibitorsIBA 11/2019 - 01/2019
2	Therapeutic UsesIBA 01/2019 - 01/2017
2	NivolumabIBA 01/2019 - 10/2018
2	SteroidsIBA 01/2019 - 01/2017

Therapy/Procedure

23	Therapeutics 12/2021 - 02/2002
8	Drug Therapy (Chemotherapy) 01/2022 - 02/2002
2	Immunotherapy 07/2022 - 01/2018
2	Chemoradiotherapy 01/2019 - 01/2019